Sio Gene Therapies Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SIOX research report →
About the company
Sio Gene Therapies Inc. is a biotechnology company in the clinical development phase, committed to pioneering gene therapies designed to fundamentally alter the prognosis for patients afflicted with neurodegenerative conditions. Its therapeutic pipeline is supported by strategic licensing agreements, including one with Oxford BioMedica (UK) Ltd.
- CEO
- David W. Nassif
- IPO
- 2015
- Employees
- 12
- HQ
- New York City, NY, US
Price Chart
- Market Cap
- $0
- P/E
- -0.49
- P/S
- 0.00
- P/B
- 0.58
- EV/EBITDA
- 0.86
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -78.26%
- ROIC
- -114.96%
- Revenue
- $0 · 0.00%
- Net Income
- $-71,887,000 · -121.70%
- EPS
- $-0.98 · -58.06%
- Op Income
- $-72,267,000
- FCF YoY
- -29.91%
- 52W High
- $0.50
- 52W Low
- $0.25
- 50D MA
- $0.39
- 200D MA
- $0.39
- Beta
- 1.08
- Avg Volume
- 62.41K
Get TickerSpark's AI analysis on SIOX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 8, 22 | Meswani Parag V | other | 153,700 |
| Feb 8, 22 | Nassif David W. | other | 546,500 |
| Jan 28, 22 | Meswani Parag V | other | 0 |
| Jan 28, 22 | Meswani Parag V | other | 15,625 |
| Jan 28, 22 | Meswani Parag V | other | 12,500 |
| Jan 28, 22 | Meswani Parag V | other | 8,033 |
| Jan 28, 22 | Meswani Parag V | other | 18,075 |
| Jan 28, 22 | Meswani Parag V | other | 219,000 |
| Dec 8, 21 | Nassif David W. | other | 17,534 |
| Dec 8, 21 | Nassif David W. | other | 6,294 |
Our SIOX coverage
Recent articles, reports, and earnings notes.
No research on SIOX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SIOX report →Similar companies
Peers in the same neighborhood.